FreedomWorks’ Bill of the Month for June 2019: The Prescription Drug Price Transparency Act, H.R. 1035
FreedomWorks is proud to announce that our bill of the month for June 2019 is the Prescription Drug Price Transparency Act, H.R. 1035, sponsored by Rep. Doug Collins (R-Ga.).
The Illegal Pricing Index
The small area of sanity in our healthcare sector is now under threat, however. A new proposal by the Department of Health and Human Services (HHS), referred to…
Regulatory Action Center Review – March 8, 2019
Welcome to FreedomWorks Foundation’s fifth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy…
Regulatory Action Center Review – February 22, 2019
Welcome to FreedomWorks Foundation’s fourth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy…
Support the CREATES Act, H.R. 965 and S. 340
On behalf of our activist community, I urge you to contact your representative and senators and ask them to support the CREATES Act, H.R. 965 and S. 340. Introduced in…
FreedomWorks Signs Coalition Letter Opposing HHS Medicare Part B Rule
FreedomWorks signed on to a coalition letter with 54 other conservative, free market advocacy groups to oppose the Department of Health and Human Services’ (HHS) proposed international pricing index (IPI).
CREATES Act Opponents are Direly Wrong
Once in a long while, Congress finds a bipartisan fix for dire issues like prescription drug prices. The CREATES Act is such a solution that would remedy price-hiking loopholes abused…
A Free Market Approach to Prescription Drugs
In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it…